Regulations.gov document
NDI 1313 - BLH308 from Onbix Corporation dba FDA Consulting
Other · FDA-2023-S-0023 · posted Mar 12, 2024
Key facts
| Document ID | FDA-2023-S-0023-0087 |
|---|---|
| Title | NDI 1313 - BLH308 from Onbix Corporation dba FDA Consulting |
| Document type | Other |
| Subtype | 75 Day PreMarket Notification |
| Agency | FDA |
| Docket | FDA-2023-S-0023 |
| Posted | Mar 12, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: